The NK1/C3 antibody was synthesized at the Netherlands Cancer Institute, and although its target antigen was not initially known, it appears to be a glycoprotein located on the membranes of cytoplasmatic vesicles in melanoma cells [81,82]. The gene discussed is C3; the disease is melanoma.